Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1425-1433

  Moss, Melissa A ^a   Zimmer, Stephen ^b   Anderson, Kimberly W ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NONE   (United States)

Author keywords

Adhesion; Cytokines; Metastasis; Parallel plate flow chamber; Tumor necrosis factor

Indexed keywords

ANTIBODY; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BREAST CANCER; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; SHEAR STRESS;

ANTIBODIES, BLOCKING; BREAST NEOPLASMS; CELL ADHESION; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

EID: 0033863821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Pauli BU et al: Organ-preference of metastasis: The role of endothelial cell adhesion molecules. Cancer and Metastasis Reviews 9: p. 175-189, 1990.
2. Kramer RH and Nicolson GL: Interaction of tumor cells with vascular endothelial cell monolayers: A model for metastatic invasion. Procedings of the National Academy of Sciences USA 76(11): 5704-5708, 1979.
3. Varani J et al: In vitro and in vivo adherence of tumor cell variants correlated with tumor formation. Amer J Pathology 101: 345-352, 1980.
4. Schandendorf D et al: Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Nat Cancer Inst 87(5): 366-371, 1995.
5. Tomita Y et al: Possible significance of VLA-4 (α4β1) for hematogenous metastasis of renal-cell cancer. Int J Cancer 60: 753-758, 1995.
6. Paavonen T et al: In vivo evidence of the role of α4β1-VCAM-1 interaction in sacroma, but not in carcinoma extravasation. Int J Cancer 58: 298-302, 1994.
7. Friedrichs K et al: High expression level of α6 integrin in human breast carcinoma is corrlated with reduced survival. Cancer Res 55: 901-906, 1995.
8. Kaufmann M et al: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345(8950): 615-619, 1995.
9. Ponta H et al: CD44 isoforms in metastatic cancer. Invasion Metastasis 14: 82-86, 1994-95.
10. Tempfer C et al: Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 32A(11): 2023-2025, 1996.
11. Mulder JWR et al: Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 36: 76-80, 1995.
12. Wielenga, VJM et al: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756, 1993.
13. Li H et al: Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res 53: 5345-5319, 1993.
14. Iida N and Bourguignon LYW: New CD44 splice variants associated with human breast cancers. J Cellular Physiol 162: 127-133, 1995.
15. Bourguignon LYW et al: Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis. J Neuro-Oncology 26: 201-208, 1995.
16. McLeskey SW et al: Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 53: 2168-2177, 1993.
17. Price JE: Metastasis from human breast cancer cell lines. Breast Cancer Res and Treatment 39: 93-102, 1996.
18. Zhang RD, Fidler IJ and Price JE: Relative malignant potential of human breast carcinoma cell lines extablished from pleural effusions and a brain metastasis. Invasion Metastasis 11: 204-215, 1991.
19. Lafrenic RM et al: The relative roles of vitronectin receptor, E-selectin and a4b1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur J Cancer 30A(14): 2151-2158, 1994.
20. Yamada N et al: Role of SPan-1 antigen in adhesion of human colon cancer cells to vascular endothelium. Difestive Diseases and Sciences 40(5): 1005-1012, 1995.
21. Mattila P, Majuri M-L and Renkonen R: VLA-4 integrin on sarcoma cell lines recognizes endothelial VCAM-1. Defferential regulation of the VLA-4 avidity on various sarcoma cell lines. Int J Cancer 52: 918-923, 1992.
22. Kawaguchi S et al: VLA-4 molecules on tumor cells initiate an adhesive interaction with VCAM-1 molecules on endothelial cell surface. Japanese J Cancer Res 83: 1304-1316, 1992.
23. Bliss RS et al: The role of b1 integrins in adhesion of two breast carcinoma cell lines to a model endothelium. Clinical and Experimental Metastasis 13: 173-183, 1995.
24. Kojima N et al: Cell adhesion in a dynamic flow system as compared to static system. J Biol Chemistry 267(24): 17264-17270, 1992.
25. Tozeren A et al: E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer 60: 426-431, 1995.
26. Goetz DJ, Brandley BK and Hammer BK: An E-selectin-IgG chimera supports sialylated moiety dependent adhesion of colon carcinoma cells under fluid flow. Ann Biomed Engineering 24: 87-98, 1996.
27. Aigner S et al: CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 12(12): 1241-1251, 1998.
28. Giavazzi R et al: Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Investig 92: 3038-3044, 1993.
29. Lawrence MB et al: Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium. Blood 75(7): 227-237, 1990.
30. Scherbarth S and Orr FW: Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: Effects of interleukin-1a on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res 57: 4105-4110, 1997.
31. Thorlacius H et al: Tumor cell arrest in the microcirculation: Lack of evidence for a leukocyte-like rolling adhesive interaction with vascular endothelium in vivo. Clin Immunol and Immunopathol 83(1): 68-76, 1997.
32. Chambers AF et al: Steps in tumor metastasis: New comcepts from intravital videomicroscopy. Cancer Metastasis Reviews 14: 279-301, 1995.
33. Haraldsen G et al: Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal microvascular endothelial cells. J Immunol 156: 2558-2565, 1996.
34. Pober JS and Cotran RS: Cytokines and endothelial cell biology. Physiological Reviews 70(2): 427-451, 1990.
35. Swerlick RA et al: Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 149(2): 698-705, 1992.
36. Vassalli P: The pathophysiology of tunor necrosis factors. Annual Review Immunol 10: 411-452, 1992.
37. Honn KV and Tang DG: Adhesion molecules and tumor cell interaction with endothelium and subendothelail matrix. Cancer Metastasis Reviews 11(3-4): 353-375, 1992.
38. Tedder TF et al. The selectins: vascular adhesion molecules. FASEB J 9: 866-873, 1995.
39. Elangham CS, Quails JCD and Dahlgren RR: Cell Adhesion Molecules-Update. Vet Pathology 34: 61-73, 1997.
40. Iwai K et al: Importance of E-selectin (ELAM-1) and sialyl Lewis A in the adhesion of pancreatic carcinoma cells to activated endothelium. Int J Cancer 54: 972-977, 1993.
41. Lauri D et al: Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. J Nat Cancer Inst 83: 1321-1324, 1991.
42. Rice GE and Bevilacqua MP: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303-1306, 1989.
43. Steinbach F et al: The influence of cytokines on the adhesion of renal cancer cells to endothelium. J Urol 155: 743-748, 1996.
44. Takada A et al: Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53: 354-361, 1993.
45. Yanase M, Tsukamoto T and Kumamoto Y: Cytokines modulate in vitro invasiveness of renal cell carcinoma cells through action on the process of cell attachment to endothelial cells. J Urol 153: 844-848, 1995.
46. Martin-Padura I et al: Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res 51: 2239-2241, 1991.
47. Nesbit M and Herlyn M: Adhesion receptors in human melanoma progression. Invasion Metastasis 14: 131-146, 1994-95.
48. Rice GE, Michael J, Gimbrone A and Bevilacqua MP: Tumor cell-endothelial interactions: Increased adhesion of human melanoma cell to activated endothelium. Amer J Pathology 133(2): 204-210, 1988.
49. Bereta M et al: Effect of inflammatory cytokines on the adherence of tumor cells to endothelium in a murine model. Cellular Immunol 136: 263-277, 1991.
50. Dejana E et al: Interleukin-1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Investig 82: 1466-1470, 1988.
51. Munn LL, Melder RJ and Jain RK: Role of erythrocytes in leukocyte-endothelial interactions: Mathematical model and experimental validation. Biophys J 71: 466-478, 1996.
52. Starkey JR et al: Influence of migratory blood cells on the attachment of tumor cells to vascular endothelium. Int J Cancer 34: 535-543, 1984.
53. Abecassis J et al: Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets. Int J Cancer 40: 525-531, 1987.
54. Warren BA: Environment of the blood-borne tumor embolus adherent to vessel wall. J Medicine 4: 150-177, 1973.
55. Hakomori S-i: Novel endothelial cell activation factor(s) released from activated platelets which induce E-selectin expression and tumor cell adhesion to endothelial cells: A preliminary note. Biochem and Biophys Res Commun 203(3): 1605-1613, 1994.
56. Crissman JD et al: Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48(14): 4065-4072, 1988.
57. Sepp NT et al: A factor in human plasma permits persistent expression of E-selectin by human endothelial cells. J Investigative Dermatol 102: 445-450, 1994.